Sandoz Strikes US Settlements to Resolve Generic Drug Price Dispute
The deal would resolve remaining U.S. state claims and class actions, with $400 million paid over seven years and no admission of wrongdoing.
- On Monday, Sandoz agreed to pay $450 million to settle antitrust litigation with 43 U.S. states, resolving allegations that the generic drug manufacturer conspired with competitors to artificially inflate prices.
- Attorney General Jeff Jackson reached the settlement following years of investigations into suspected industry-wide price-fixing, alleging the company worked with competitors to discourage competition and raise profits.
- Sandoz will pay $400 million over seven years starting in 2027, plus $50 million to previously settling states, with the agreement containing no admission of wrongdoing by Sandoz Inc. or Fougera Pharmaceuticals.
- Separately, Sandoz finalized a $28.5 million agreement to resolve class-action litigation brought by indirect resellers, compensating retail pharmacies, hospitals, and clinics that purchased medicines during the alleged misconduct.
- These settlements resolve all pending U.S. federal and state governmental claims against the company, with ZKB analysts noting the agreement "brings clarity" to the legal dispute and "reduces potential risks for the future.
28 Articles
28 Articles
AG Fitch secures settlement to lower drug costs
Attorney General Fitch joined a coalition of 43 states and territories announcing a $400 million settlement in principle with Sandoz Inc. to resolve allegations that the generic drug manufacturer engaged in widespread, long-running conspiracies to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade with regard to numerous generic prescription drugs. “Generic drugs are supposed to be a more affordable a…
Oklahoma Attorney General Announces $469,000,000 Multi-State Settlement With Sandoz Over Alleged Generic Drug Price-Fixing
A multistate coalition has reached a $469 million settlement with Sandoz Inc. to resolve allegations of price-fixing on generic drugs. The deal includes compliance reforms and forms part of wider litigation against multiple manufacturers. The post Oklahoma Attorney General Announces $469,000,000 Multi-State Settlement With Sandoz Over Alleged Generic Drug Price-Fixing appeared first on The Daily Hodl.
Tennessee, Others Obtain Settlement in Alleged Drug Price Fixing Scheme
Tennessee secured a settlement with a generic drug company over an alleged price-fixing scheme. A coalition of 43 states and territories announced a $400 million settlement to resolve allegations that Sandoz inflated its generic drug prices, limited competition, and restricted trade.
The Basel group saw its profit decline by 71% in the first half of the year. Monday, it announced that it had reached agreements to end complaints in the United States for more than 470 million dollars in a decade-old caseBy stopping at the profit published Wednesday by Sandoz for the first half of 2026, one might think that the Basel pharmaceutical group has lead in the wing. The specialist of generic and biosimilar medicines has seen its net p…
Coverage Details
Bias Distribution
- 57% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
